↓ Skip to main content
Embed badge What is this page?

Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

Overview of attention for article published in The Lancet, January 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
17 news outlets
blogs
2 blogs
policy
2 policy sources
twitter
34 tweeters
facebook
9 Facebook pages
wikipedia
2 Wikipedia pages
googleplus
2 Google+ users
reddit
1 Redditor
f1000
1 research highlight platform
video
2 video uploaders

Readers on

mendeley
183 Mendeley

What is this page?

Summary News Blogs Policy documents Twitter Facebook Wikipedia Google+ Reddit Research highlights Video
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
Published in
The Lancet, January 2013
DOI 10.1016/s0140-6736(13)61950-9
Pubmed ID
24224997
Authors

Jayant S Vaidya, Frederik Wenz, Max Bulsara, Jeffrey S Tobias, David J Joseph, Mohammed Keshtgar, Henrik L Flyger, Samuele Massarut, Michael Alvarado, Christobel Saunders, Wolfgang Eiermann, Marinos Metaxas, Elena Sperk, Marc Sütterlin, Douglas Brown, Laura Esserman, Mario Roncadin, Alastair Thompson, John A Dewar, Helle M R Holtveg, Steffi Pigorsch, Mary Falzon, Eleanor Harris, April Matthews, Chris Brew-Graves, Ingrid Potyka, Tammy Corica, Norman R Williams, Michael Baum, Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, Flyger HL, Massarut S, Alvarado M, Saunders C, Eiermann W, Metaxas M, Sperk E, Sütterlin M, Brown D, Esserman L, Roncadin M, Thompson A, Dewar JA, Holtveg HM, Pigorsch S, Falzon M, Harris E, Matthews A, Brew-Graves C, Potyka I, Corica T, Williams NR, Baum M

Abstract

The TARGIT-A trial compared risk-adapted radiotherapy using single-dose targeted intraoperative radiotherapy (TARGIT) versus fractionated external beam radiotherapy (EBRT) for breast cancer. We report 5-year results for local recurrence and the first analysis of overall survival.

View on publisher site

Twitter Demographics

The data shown below were collected from the profiles of 34 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 183 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 2%
United States 3 2%
Germany 1 <1%
Slovenia 1 <1%
Denmark 1 <1%
Taiwan 1 <1%
Netherlands 1 <1%
Canada 1 <1%
India 1 <1%
Other 4 2%
Unknown 166 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 35 19%
Student > Postgraduate 27 15%
Other 26 14%
Student > Master 21 11%
Student > Ph. D. Student 19 10%
Other 55 30%
Readers by discipline Count As %
Medicine and Dentistry 144 79%
Physics and Astronomy 12 7%
Engineering 7 4%
Unspecified 6 3%
Agricultural and Biological Sciences 2 1%
Other 12 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 181. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2016.
All research outputs
#34,045
of 7,758,973 outputs
Outputs from The Lancet
#584
of 22,666 outputs
Outputs of similar age
#697
of 145,719 outputs
Outputs of similar age from The Lancet
#8
of 405 outputs
Altmetric has tracked 7,758,973 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,666 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 145,719 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 405 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.

This page is provided by Altmetric.